Amber Therapeutics Revenue and Competitors

London, England

Location

#8251

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Amber Therapeutics's estimated annual revenue is currently $3.8M per year.(i)
  • Amber Therapeutics's estimated revenue per employee is $77,500
  • Amber Therapeutics's total funding is $101M.

Employee Data

  • Amber Therapeutics has 49 Employees.(i)
  • Amber Therapeutics grew their employee count by 40% last year.

Amber Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder, CEOReveal Email/Phone
2
Co-founder & Chief ScientistReveal Email/Phone
3
CMOReveal Email/Phone
4
VP Regulatory, Clinical, QualityReveal Email/Phone
5
Director R&DReveal Email/Phone
6
Director Clinical AffairsReveal Email/Phone
7
Hardware & Systems Engineering ManagerReveal Email/Phone
8
Senior Supply Chain ManagerReveal Email/Phone
9
Quality Operations ManagerReveal Email/Phone
10
Finance ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M2210%N/AN/A
#2
$2.1M2713%N/AN/A
#3
$0.5M6-14%N/AN/A
#4
$3.6M4621%N/AN/A
#5
$2.2M280%$21.8MN/A
#6
$2.1M270%N/AN/A
#7
$5.7M734%$37.7MN/A
#8
$2.4M3119%$191MN/A
#9
$1.9M2450%N/AN/A
#10
$3.6M4618%$21.9MN/A
Add Company

What Is Amber Therapeutics?

Amber Therapeutics is a University of Oxford spinout developing next-generation, intelligent bioelectrical therapies to transform clinical outcomes in patients with functional disorders of the peripheral nervous system. Amber’s approach leverages closed-loop intelligence to create ‘synthetic reflex arcs’ that can sense, interpret, adapt and respond to a patient’s individual signals thereby restoring normal physiological function. Amber Therapeutics was founded by a multidisciplinary team of clinicians, translational neuroengineers, medtech industry professionals and experienced entrepreneurs focused on developing transformational therapy innovation for major unmet medical conditions. The Company was spun out from the University of Oxford in 2021 and is backed by Oxford Science Enterprises and 8VC.

keywords:N/A

$101M

Total Funding

49

Number of Employees

$3.8M

Revenue (est)

40%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M494%N/A
#2
$8M4917%N/A
#3
$6.5M49-8%N/A
#4
$4.7M4926%N/A
#5
$8.9M4914%N/A